[Reactivation of the cryopyrin-associated periodic syndrome after vaccination in a patient who is a candidate for immunosuppression]

M Fernández-Prada; J Rugeles-Niño; L Suárez-Pérez; M Ruiz-Álvarez; J B López-Díaz; J Fernández-Madera; C Martínez-Ortega; I Huerta-González

[Reactivation of the cryopyrin-associated periodic syndrome after vaccination in a patient who is a candidate for immunosuppression]

Rev Esp Quimioter. 2019 Aug;32(4):379-380. Epub 2019 Jul 24.

[Article in Spanish]

Authors

M Fernández-Prada¹, J Rugeles-Niño, L Suárez-Pérez, M Ruiz-Álvarez, J B López-Díaz, J Fernández-Madera, C Martínez-Ortega, I Huerta-González

Affiliation

¹ María Fernández-Prada. Servicio de Medicina Preventiva y Salud Pública. Hospital Vital Álvarez Buylla. Mieres, Asturias, Spain. mariafdezprada@gmail.com.

PMID: 31241279
PMCID: PMC6719656

No abstract available

©The Author 2019. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).

Publication types

Case Reports
Letter

MeSH terms

Antirheumatic Agents / therapeutic use
Cryopyrin-Associated Periodic Syndromes / etiology*
Cryopyrin-Associated Periodic Syndromes / genetics
Cryopyrin-Associated Periodic Syndromes / therapy
Female
Hepatitis B Vaccines / adverse effects*
Humans
Immunosuppression Therapy
Interleukin 1 Receptor Antagonist Protein / therapeutic use
Measles-Mumps-Rubella Vaccine / adverse effects*
Symptom Flare Up*
Young Adult

Substances

Antirheumatic Agents
Hepatitis B Vaccines
Interleukin 1 Receptor Antagonist Protein
Measles-Mumps-Rubella Vaccine